Pleyer, Lisa Burgstaller, Sonja Stauder, Reinhard Girschikofsky, Michael Sill, Heinz Schlick, Konstantin Thaler, Josef Halter, Britta Machherndl-Spandl, Sigrid Zebisch, Armin Pichler, Angelika PfeilstĂścker, Michael Autzinger, Eva-Maria Lang, Alois Geissler, Klaus Voskova, Daniela Geissler, Dietmar Sperr, Wolfgang Hojas, Sabine Rogulj, Inga Andel, Johannes Greil, Richard Additional file 2: Table S2. of Azacitidine front-line in 339 patients with myelodysplastic syndromes and acute myeloid leukaemia: comparison of French-American-British and World Health Organization classifications Treatment after azacitidine in young patients. (DOC 40 kb) AML;MDS;WHO;FAB;Classification;RAEB-t;Bone marrow blast count;Azacitidine;Austrian Azacitidine Registry 2016-04-16
    https://springernature.figshare.com/articles/journal_contribution/Additional_file_2_Table_S2_of_Azacitidine_front-line_in_339_patients_with_myelodysplastic_syndromes_and_acute_myeloid_leukaemia_comparison_of_French-American-British_and_World_Health_Organization_classifications/4363442
10.6084/m9.figshare.c.3611363_D1.v1